Clinical Trials

12 enrolled

Pancreatic Neoplasms

NCT05311618 2024-04-01

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

71 enrolled

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Melanoma, Mesothelioma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT05783570 2024-03-15

To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307

12 enrolled

Carcinoma, Hepatocellular

NCT05872867 2024-03-12

MK-3475-E90

GastrointestinalHead & NeckThoracic

54 enrolled

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT06304597 2024-03-12

PREDICT

18 enrolled

Locally Advanced Rectal Carcinoma

NCT06300489 2024-03-08

Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

Rectal Neoplasms

NCT05472857 2024-03-06

Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression

Pancreatic Neoplasms, Stomach Neoplasms

NCT06225921 2024-03-06

Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas

6 enrolled

Esophageal Squamous Cell Carcinoma

NCT06283303 2024-02-29

A Clinical Study of T3011 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer

8 enrolled

Colorectal Neoplasms

NCT06281860 2024-02-28

PITHAC

BreastGastrointestinalGynecologicOther solid neoplasmThoracic

39 enrolled

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT06075849 2024-02-23

Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent

Carcinoma, Hepatocellular, Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT05829057 2024-02-13

The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1

GastrointestinalGenitourinaryGynecologicThoracic

10 enrolled

Urinary Bladder Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Neoplasms, Ovarian Neoplasms, Small Cell Lung Carcinoma

NCT05028933 2024-02-12

IMC001 for Clinical Research on Advanced Digestive System Malignancies

Advanced Hepatocellular Carcinoma

NCT05213195 2024-02-12

NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer

38 enrolled

Colorectal Neoplasms

NCT04149691 2024-02-07

Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies

GastrointestinalGenitourinaryGynecologicSarcoma

42 enrolled

Urinary Bladder Neoplasms, Carcinoma, Neoplasms, Sarcoma, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT05787535 2024-02-02

HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor

GastrointestinalGenitourinaryGynecologicHead & Neck

17 enrolled

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT05861947 2024-01-31

JIVAN

GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Colonic Neoplasms, Esophageal Neoplasms, Kidney Neoplasms, Recurrence, Stomach Neoplasms

NCT06010901 2024-01-23

A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer.

75 enrolled

Colorectal Neoplasms

NCT04224480 2024-01-19

Longitudinal Immune-phenotyping of HCC Following MK-3475

8 enrolled

Carcinoma, Hepatocellular

NCT06200363 2024-01-11

A Clinical Study of T3011 in Combination With Regorafenib in Patients With Advanced Colorectal Cancer

15 enrolled

Advanced Colorectal Cancer

NCT05185531 2024-01-05

Notable-HCC

Carcinoma, Hepatocellular

NCT05415475 2024-01-05

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors

36 enrolled

Esophageal Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Recurrence, Stomach Neoplasms, Colorectal Neoplasms

NCT06144385 2024-01-02

A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma

Carcinoma, Hepatocellular

NCT04324294 2023-12-20

Contrast Enhanced Endoscopic Ultrasound in Pancreas Lesions

200 enrolled

Pancreatic Cyst, Pancreatic Neoplasms, Pancreatitis

NCT05031949 2023-12-19

CCGLC-003

Carcinoma, Hepatocellular

NCT05533892 2023-12-19

CCGLC-007

Carcinoma, Hepatocellular

NCT05514158 2023-12-18

To Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Disitamab Vedotin Combined With RC98 in the Treatment of Subjects With HER2-expressing Locally Advanced or Metastatic Gastric Cancer (Including AEG)

24 enrolled

Stomach Neoplasms

NCT04450732 2023-12-05

Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors

96 enrolled

GastrointestinalThoracic

Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT05088889 2023-11-28

Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer

10 enrolled

Pancreatic Neoplasms

NCT02915445 2023-11-22

EpCAM CAR-T for Treatment of Advanced Solid Tumors

BreastGastrointestinalHead & NeckOther neoplasm

Malignant Neoplasm of Nasopharynx TNM Staging Distant Metastasis (M)

NCT04338763 2023-11-18

RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic Cancer

Pancreatic Neoplasms

NCT03129139 2023-10-18

Minnelide 101

66 enrolled

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Stomach Neoplasms

NCT05566834 2023-10-18

Minnelide™ Capsules Alone and in Combination With Paclitaxel in Advanced Gastric Cancer

36 enrolled

Stomach Neoplasms

NCT06088459 2023-10-18

NWRD06 DNA Plasmid for HCC After Radical Resection

9 enrolled

Carcinoma, Hepatocellular

NCT06081322 2023-10-13

CISPD-5

29 enrolled

Cholangiocarcinoma

NCT06078800 2023-10-12

A Study of YL-17231 in Patients With Advanced Solid Tumors

80 enrolled

Pancreatic Neoplasms

NCT06078982 2023-10-12

Posterior-line Treatment With Disitamab Vedotin Plus PD-1 in Advanced HER2-low Expressing Gastric Cancer

39 enrolled

Stomach Neoplasms

NCT04303403 2023-10-11

Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic Adenocarcinoma

Colorectal Neoplasms

NCT06065592 2023-10-06

CAT_PB

BreastGastrointestinalGenitourinaryThoracic

500 enrolled

Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Carcinoma, Hepatocellular, Immune System Diseases, Inflammation, Lung Neoplasms, Neoplasms, Prostatic Neoplasms, Thromboembolism, Thrombosis

NCT05352646 2023-09-28

NewishT Cell Therapy for HCC With High Risk of Recurrence After Radical Resection

26 enrolled

Carcinoma, Hepatocellular

NCT06006338 2023-09-21

3D Printed Models for Liver Surgery

5 enrolled

Liver Neoplasms

NCT05955833 2023-07-21

HER Image

6 enrolled

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms

NCT05089266 2023-07-17

Study of αPD1-MSLN-CAR T Cells to Evaluate the Safety, Tolerability, and Effectiveness for Patients With MSLN-positive Advanced Solid Tumors

Colorectal Neoplasms

NCT05927844 2023-07-03

XH-30002 Capsule Combined With Afatinib Tablets for the Treatment of Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

NCT05780307 2023-06-07

IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors